Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Oppenheimer raises its price target for Questcor Pharma (QCOR +3%) to $69 from $59 after...

  • Tuesday, September 18, 2012, 9:34 AM ET
    Oppenheimer raises its price target for Questcor Pharma (QCOR +3%) to $69 from $59 after positive commentary from investor meetings. Investors are becoming more comfortable with QCOR's perceived risks, the firm says, and any additional negative reports will result in limited downside volatility. Acthar reimbursement rates remain “extremely strong,” the firm adds.
Track new comments on this story

This news story has 2 comments:

  •  
    Thats hilarious!
    19 Sep 2012, 01:38 PM Reply Like
  •  
    I wonder if this firm (the "recommender") will ever recover from this. I see the put series showing 1000 to 20000% gains overnight. I wonder if this will trigger an investigation into all far out Put positions taken yesterday and earlier today.
    19 Sep 2012, 03:57 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »